Fig 1.

Continuous glucose monitor tracing for 3 consecutive days while the patient was on lispro 30 units prior to breakfast (at 07:00 hours), 18 units prior to lunch (at 12:00 hours), and 17 units prior to dinner (at 16:00 hours) along with A, alpelisib 300 mg and 25 mg empagliflozin at 19:30 hours and degludec 60 units taken at 23:00 hours; B, alpelisib 300 mg and 25 mg empagliflozin 23:00 hours and degludec 60 units taken at 23:00 hours; and C, alpelisib 300 mg and 25 mg empagliflozin at 19:00 hours and degludec 60 units taken at 22:00 hours.